
In Oral Arguments, Supreme Court Seems to Side with ACA Preventive Care Rule
Legal case involves major implications for health insurance coverage nationwide
Legal case involves major implications for health insurance coverage nationwide
Aeroflow Health has launched a new diabetes program that offers educational content on diabetes management, medical nutrition therapy and more. The post Aeroflow Health Unveils New Diabetes Management Program appeared first on MedCity News.
KFF resources on U.S. funding for global health, including the range of efforts the U.S. supports, U.S. agencies/departments involved in global health activities, funding trends, and more
Enhertu is currently approved as a second-line treatment for HER2-positive metastatic breast cancer. The new results for the AstraZeneca and Daiichi Sankyo drug in the first-line setting are important because many patients do not live long enough to receive a second-line cancer therapy. The post AstraZeneca & Daiichi Sankyo’s Enhertu Posts Positive Data as First-Line…
UnitedHealth Group executives also say the measure forbidding simultaneous ownership of pharmacies and PBMs will hurt patients’ access to medicines. Both companies said they will work with lawmakers on possible solutions.
Earlier this month Sachin Jain, CEO of SCAN Health Plan, a nonprofit Medicare Advantage company, provided some refreshing straight talk on what is wrong with MA while stressing that it is far better than traditional Medicare for seniors. The post Medicare Advantage CEO: My Baby is Ugly…(video) appeared first on MedCity News.
Fact sheet examining actions taken by the Trump administration and their impact on global health security and pandemic preparedness.
Fact sheet examining actions taken by the Trump administration and their impact on global maternal and child health.
Fact sheet examining actions taken by the Trump administration and their impact on the President’s Malaria Initiative (PMI).
Fact sheet examining actions taken by the Trump administration and their impact on PEPFAR.